Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ulrich Pirron"'
Autor:
Ruben A. Mesa, Simon Durrant, Fabrizio Pane, Dany Habr, Srdan Verstovsek, William M. Garrett, Martin Griesshammer, Shui He, Jean-Jacques Kiladjian, Ulrich Pirron, Jingjin Li, Pierre Zachee, Mark M. Jones, Tamás Masszi, Alessandro M. Vannucchi, Claire N. Harrison, Francesco Passamonti
Background Ruxolitinib, a Janus kinase (JAK) 1 and 2 inhibitor, was shown to have a clinical benefit in patients with polycythemia vera in a phase 2 study. We conducted a phase 3 open-label study to evaluate the efficacy and safety of ruxolitinib ver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e524420fd588cd718d3c58b79eea8764
https://europepmc.org/articles/PMC4358820/
https://europepmc.org/articles/PMC4358820/
Autor:
Ulrich Pirron, Gregory I Snell, P Vitulo, A. Hmissi, Robert M. Aris, Allan R. Glanville, James E. Loyd, Amparo Solé, David C. McGiffin, Vincent G. Valentine, Antonio Roman
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 6(1)
Everolimus is a proliferation signal inhibitor with immunosuppressive activity that may reduce the rate of progression of chronic rejection, bronchiolitis obliterans syndrome (BOS), after lung transplantation. In a randomized, double-blind clinical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c27976814ea0e41ffaec2891674d033
https://pubmed.ncbi.nlm.nih.gov/16433771
https://pubmed.ncbi.nlm.nih.gov/16433771
Autor:
John M. Kovarik, Charles K. Chan, Robert M. Aris, Gregory I Snell, Ulrich Pirron, Heinz Schmidli, Vincent G. Valentine
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 25(4)
Background In this study we evaluated exposure, safety and efficacy data from an international trial of everolimus. We sought to identify a tolerated and efficacious range for blood levels of this agent in maintenance lung transplant recipients. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cfad09141db65d00503b66ae3b2a5de
https://pubmed.ncbi.nlm.nih.gov/16563975
https://pubmed.ncbi.nlm.nih.gov/16563975
Autor:
Francesco Passamonti, Pierre Zachee, Ruben A. Mesa, Simon Durrant, Mark M. Jones, Jean-Jacques Kiladjian, Ulrich Pirron, William M. Garrett, Tomasz Lawniczek, Martin Griesshammer, Srdan Verstovsek, Jingjin Li, Tamas Masszi, Shui He, Claire N. Harrison, Fabrizio Pane, Alessandro M. Vannucchi
Publikováno v:
Journal of Clinical Oncology. 32:7026-7026
7026 Background: PV is a myeloproliferative neoplasm characterized by increased erythrocytosis, disease-related symptom burden (eg, pruritus), and risk of vascular events (thrombosis and/or hemorrh...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98890b44b55e4dc29e394f51c8177c43
https://doi.org/10.1200/jco.2014.32.15_suppl.7026
https://doi.org/10.1200/jco.2014.32.15_suppl.7026
Autor:
Alessandro M. Vannucchi, Jean-Jacques Kiladjian, Martin Griesshammer, Tamás Masszi, Simon Durrant, Pierre Zachee, Fabrizio Pane, Claire N Harrison, Shui He, Lance Leopold, Jingjin Li, Ulrich Pirron, Tomasz Lawniczek, Srdan Verstovsek
Publikováno v:
Blood. 122:4071-4071
Background Polycythemia vera (PV) is the most common of the myeloproliferative neoplasms and is characterized by elevated hematocrit requiring phlebotomy, splenomegaly, a variety of symptoms and increased thrombotic risk. Ruxolitinib, a JAK1/JAK2 inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::207e2d2829b825b610762ba6eed1ba1c
https://doi.org/10.1182/blood.v122.21.4071.4071
https://doi.org/10.1182/blood.v122.21.4071.4071
Autor:
Vincent G. Valentine, Gregory I Snell, P Vitulo, Ulrich Pirron, Robert B. Love, Allan R. Glanville
Publikováno v:
The Journal of Heart and Lung Transplantation. 22:S207-S208
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78445c72deb3b42a4391627a2519f87b
https://doi.org/10.1016/s1053-2498(02)01106-3
https://doi.org/10.1016/s1053-2498(02)01106-3
Autor:
Srdan Verstovsek, Jacek Lukawy, Jingjin Li, Ulrich Pirron, Bijoyesh Mookerjee, Jean-Jacques Kiladjian, Victor Sandor, Alessandro M. Vannucchi, Shui He, William M. Garrett, Kamel Malek
Publikováno v:
Journal of Clinical Oncology. 30:TPS6643-TPS6643
TPS6643^ Background: PV is a myeloproliferative neoplasm characterized by clonal stem cell proliferation, significant morbidity, shortened life span and possible evolution to myelofibrosis and acute myeloid leukemia. Splenomegaly, debilitating consti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fac60c3f8cdebb6cd0a48e54569adb5
https://doi.org/10.1200/jco.2012.30.15_suppl.tps6643
https://doi.org/10.1200/jco.2012.30.15_suppl.tps6643
Autor:
Vincent G. Valentine, P Vitulo, Ulrich Pirron, Gregory I Snell, Robert B. Love, Allan R. Glanville
Publikováno v:
The Journal of Heart and Lung Transplantation. 23:S45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c07c03af9d6ded4d83b75fab60dd5e34
https://doi.org/10.1016/j.healun.2003.11.012
https://doi.org/10.1016/j.healun.2003.11.012
Publikováno v:
The Journal of Heart and Lung Transplantation. 23:S142
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e986d074dba70b99af7b4b937d92567b
https://doi.org/10.1016/j.healun.2003.11.296
https://doi.org/10.1016/j.healun.2003.11.296